Klingman & Associates, LLC Novartis Ag Transaction History
Klingman & Associates, LLC
- $1.61 Billion
- Q3 2024
A detailed history of Klingman & Associates, LLC transactions in Novartis Ag stock. As of the latest transaction made, Klingman & Associates, LLC holds 2,638 shares of NVS stock, worth $275,090. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,638
Previous 2,625
0.5%
Holding current value
$275,090
Previous $279,000
8.6%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding NVS
# of Institutions
1,435Shares Held
133MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.27 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.25 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$844 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$728 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$602 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $224B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...